Recurrence Rate of Idiopathic Sudden Low-Tone Sensorineural Hearing Loss Without Vertigo

Fushiki, Hiroaki; Junicho, Makiko; Aso, Shin; Watanabe, Yukio

doi:10.1097/mao.0b013e31819d3496

Cited by 35 publications

(25 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The follow‐up period after the initiation of treatment for ISSNHL varied in other reports. Gundogan et al, for example, advocated a 1‐month follow‐up, Battaglia et al a 2‐month follow‐up, Filipo et al a specific (1‐year) long‐term follow‐up, and Fushiki et al a nonspecific long‐term follow‐up . We chose a 2‐month follow‐up time because < 8% of patients are expected to experience further hearing improvement after 2 months .…”

Section: Discussionmentioning

confidence: 99%

Effect of comorbid diabetes and hypercholesterolemia on the prognosis of idiopathic sudden sensorineural hearing loss

Lin

Lee

et al. 2015

The Laryngoscope

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Effect of comorbid diabetes and hypercholesterolemia on the prognosis of idiopathic sudden sensorineural hearing loss

Lin

Lee

et al. 2015

The Laryngoscope

View full text Add to dashboard Cite

show abstract

“…The presence of nystagmus is proposed to lead to the development of EH that spreads from the cochlea to the vestibule. If ALHL can be assumed to be the precursor stage of MD and a less severe state of EH, evaluation of the severity and extent of EH within the inner ear at the initial presentation may be useful in predicting whether ALHL patients develop definite MD and present with recurrent hearing loss [Fuse et al, 2003;Fushiki et al, 2009;Shimono et al, 2013]. The value of using electrocochleography and vestibular-evoked myogenic potentials in predicting the outcome of ALHL has also been reported [Wang et al, 2010;Yamasoba et al, 1993].…”

Section: Discussionmentioning

confidence: 99%

“…Although the short-term hearing outcomes are relatively good, the rates of recurrence and progression to MD in ALHL patients are estimated to be 27-47 and 9-11% during the long-term follow-up [Fushiki et al, 2009;Junicho et al, 2008;Yamasoba et al, 1994]. In the current study, the 5-year estimated recurrence and progression rates were 24.7 and 12.3% among the total patients, and we did not find that ITS administration aided in the control of these incidents during the long-term follow-up of at least 1 year.…”

Section: Discussionmentioning

confidence: 99%

“…ALHL appears to partially overlap with the low-tone type of idiopathic sudden sensorineural hearing loss (ISSNHL). However, it was revealed that ALHL has a relatively high incidence of spontaneous hearing recovery as well as recurrence and/ or progression to definite Ménière's disease (MD) after a long-term follow-up [Fushiki et al, 2009;Imamura et al, 1997;Junicho et al, 2008;Yamasoba et al, 1994]. These characteristic clinical courses, together with the results of electrocochleographic examination, glycerol tests, vestibular-evoked myogenic potential and 3-tesla magnetic resonance imaging (MRI) after intratympanic or intravenous gadolinium injection, suggest that the pathogenesis of ALHL may be attributable to cochlea-specific endolymphatic hydrops (EH) [Junicho et al, 2008;Noguchi et al, 2004;Nozawa et al, 2002;Shimono et al, 2013;Wang et al, 2010;Yamasoba et al, 1993Yamasoba et al, , 1994.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Short- and Long-Term Outcome of Intratympanic Steroid Therapy as a Salvage Treatment for Acute Low-Tone Sensorineural Hearing Loss without Episodes of Vertigo

et al. 2016

View full text Add to dashboard Cite

Objectives: To evaluate the hearing outcomes of intratympanic steroid (ITS) treatment for patients with acute low-tone sensorineural hearing loss (ALHL) after failure of initial therapy and to investigate the recurrence and progression to definite Ménière's disease (MD) during a long-term follow-up. Methods: We retrospectively reviewed the medical records of 90 patients with refractory ALHL who were followed up for at least 1 year between January 2000 and April 2014. Patients who responded poorly to initial medical treatment received intratympanic dexamethasone injections (ITS group) or isosorbide administration for 4 weeks (diuretic group) as salvage treatment options according to their choice of management. The control group did not receive ITS or the diuretic, due to their refusal of both medical treatments. The hearing outcomes were evaluated 1 month, 1 year and 5 years after the completion of the second-line therapy, and the rates of recurrence and progression to MD were measured during a follow-up period of at least 1 year. Results: Twenty-seven patients in the ITS group, 39 patients in the diuretic group and 24 patients in the control group were enrolled. Of these, 12 patients in the ITS group, 15 patients in the diuretic group and 12 patients in the control group were followed up for over 5 years. We found that the recovery rates and the audiometric functional values after 1 month and 1 year in the ITS group were significantly higher than those in the diuretic and control groups. However, there were no significant differences in the recovery rates or the audiometric functional values after 5 years, or in the rates of recurrence and progression to MD between the groups. Conclusions: Salvage ITS therapy can provide a relatively good short-term hearing outcome for ALHL patients who have persistent hearing loss despite conventional treatment. However, both recurrence and progression to MD after treatment were observed in some patients during the long-term follow-up.

show abstract

“…However, recurrence of hearing loss and possible progression to Meniere's disease remain important concerns in the clinical setting [ 4 6 7 ]. In a previous report, the rate of recurrence was about 40% [ 8 ], and the rate of progression to Meniere's disease was about 11% [ 4 ].…”

Section: Introductionmentioning

confidence: 99%

Long-Term Outcomes of Acute Low-Tone Hearing Loss

et al. 2015

View full text Add to dashboard Cite

Background and ObjectivesAlthough acute low-tone hearing loss has been associated with cochlear hydrops or early stage Meniere's disease, its prognosis in the short-term has been reported to be better than sudden hearing loss. However, recurrence of hearing loss and possible progression to Meniere's disease remain important concerns in the clinical setting. This study aims to investigate the long-term audiological outcomes of acute low-tone hearing loss.Subjects and MethodsA retrospective review of patients presenting with a first attack of acute low-tone hearing loss was performed. Of the 77 patients, 33 were followed up for more than 3 months. Progression, recovery of hearing loss and recurrence of hearing loss were examined. Also, correlation between long-term outcomes and associated clinical factors were analyzed.ResultsTwenty-five patients (75.7%) had complete hearing recovery, five patients (15.1%) had partial recovery, two patients (6.0%) had no recovery, and one patient (3.0%) had progression of hearing loss 1 month after initial treatment. Thirty-three patients were followed up for more than 3 months (mean 22 months, range 3-79 months). Recurrences of acute low-tone hearing loss were observed in five patients (15.2%). All of the recurrences occurred during the first 12 months of follow-up. Long-term prognosis correlated with the initial therapy results (R2=0.693).ConclusionsRecurrences of hearing loss were documented in five patients (15.2%), and all of these cases occurred within one year of the first attack. Audiological outcomes after initial therapy may predict the recurrence of acute low-tone hearing loss.

show abstract

Recurrence Rate of Idiopathic Sudden Low-Tone Sensorineural Hearing Loss Without Vertigo

Cited by 35 publications

References 12 publications

Effect of comorbid diabetes and hypercholesterolemia on the prognosis of idiopathic sudden sensorineural hearing loss

Effect of comorbid diabetes and hypercholesterolemia on the prognosis of idiopathic sudden sensorineural hearing loss

The Short- and Long-Term Outcome of Intratympanic Steroid Therapy as a Salvage Treatment for Acute Low-Tone Sensorineural Hearing Loss without Episodes of Vertigo

Long-Term Outcomes of Acute Low-Tone Hearing Loss

Contact Info

Product

Resources

About